Advertisement
Screener

Quantum Cyber N.V. (QUCY) Graph

QUCY Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Revenue (m); Research and development $4.55M; Selling, general and administrative (m); Operating expenses $9.89M.
  • 2026-03-31: Revenue (m); Research and development $59.30K; Selling, general and administrative (m); Operating expenses $2.46M.
  • 2025-06-30: Revenue (m); Research and development $101.28K; Selling, general and administrative (m); Operating expenses $1.63M.
  • 2025-03-31: Revenue (m); Research and development $88.75K; Selling, general and administrative (m); Operating expenses $2.75M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30(m)$4.55M(m)$9.89M-$11.02M
2026-03-31(m)$59.30K(m)$2.46M-$5.08M
2025-06-30(m)$101.28K(m)$1.63M-$3.48M
2025-03-31(m)$88.75K(m)$2.75M-$5.00M
2023-09-30(m)$1.85M(m)(m)(m)
2023-06-30(m)$3.48M(m)(m)(m)
2023-03-31$1.00$2.63M$1.59M(m)(m)
2022-09-30(m)$909.00K(m)(m)(m)
2022-06-30(m)$229.92K(m)(m)(m)
2022-03-31(m)$563.57K$4.19M(m)(m)

Revenue and expense 6 month

Period endResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$4.58M(m)$12.35M-$16.10M
2025-06-30$190.03K(m)$4.38M-$8.48M
2024-06-30$3.24M$4.52M(m)(m)
2023-06-30$5.48M$5.23M(m)(m)
2022-06-30$793.49K(m)(m)(m)
2021-06-30$206.15K(m)(m)(m)

Revenue and expense 9 month

Period endResearch and development
2023-09-30$7.59M
2022-09-30$1.70M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2025-12-31$537.08K$147.29K$4.91M(m)$16.53M-$16.21M
2024-12-31$893.99K$319.11K$5.72M(m)$19.35M-$21.60M
2023-12-31(m)(m)$9.59M$11.41M(m)(m)
2022-12-31(m)(m)$5.02M$15.21M(m)(m)
2021-12-31(m)(m)$481.93K$8.46M(m)(m)
2020-12-31(m)(m)$311.85K$374.57K(m)(m)
2019-12-31(m)(m)$250.32K(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immuneering Corp (IMRX)United States$0.113B-12.51
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80